Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average of $3.89

Sensus Healthcare, Inc. (NASDAQ:SRTS)’s stock price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $3.89 and traded as low as $3.24. Sensus Healthcare shares last traded at $3.29, with a volume of 93,314 shares trading hands.

Sensus Healthcare Stock Performance

The firm has a market cap of $53.92 million, a price-to-earnings ratio of 109.70 and a beta of 0.91. The company’s fifty day moving average is $3.89 and its two-hundred day moving average is $3.02.

Sensus Healthcare (NASDAQ:SRTS) last posted its earnings results on Thursday, February 8th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.14. The business had revenue of $12.57 million for the quarter, compared to analyst estimates of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a return on equity of 1.04%. As a group, analysts forecast that Sensus Healthcare, Inc. will post 0.08 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Sensus Healthcare

A number of institutional investors have recently added to or reduced their stakes in the company. Creekmur Asset Management LLC purchased a new position in Sensus Healthcare in the 4th quarter valued at about $83,000. Perritt Capital Management Inc. boosted its position in Sensus Healthcare by 23.7% in the 4th quarter. Perritt Capital Management Inc. now owns 130,586 shares of the company’s stock valued at $308,000 after buying an additional 25,000 shares during the last quarter. Northern Trust Corp boosted its position in Sensus Healthcare by 169.7% in the 4th quarter. Northern Trust Corp now owns 62,051 shares of the company’s stock valued at $146,000 after buying an additional 39,040 shares during the last quarter. Sachetta LLC purchased a new position in Sensus Healthcare in the 4th quarter valued at about $247,000. Finally, Dimensional Fund Advisors LP boosted its position in Sensus Healthcare by 14.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 68,092 shares of the company’s stock valued at $161,000 after buying an additional 8,701 shares during the last quarter. Institutional investors and hedge funds own 25.30% of the company’s stock.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.